We are live on ! Find out more
UTMD icon

Utah Medical Products

74 hedge funds and large institutions have $182M invested in Utah Medical Products in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 22

2% more capital invested

Capital invested by funds: $179M → $182M (+$3.13M)

0.08% more ownership

Funds ownership: 66.6%66.68% (+0.08%)

3% less funds holding

Funds holding: 7674 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
74
Holders Change
-2
Holders Change %
-2.63%
% of All Funds
1.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
35
Reduced
22
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
$268K -$8.27K -115 -3%
ASN
52
Advisory Services Network
Georgia
$260K +$193K +2,690 +316%
EHC
53
Everett Harris & Co
California
$244K +$30.6K +425 +15%
SEI Investments
54
SEI Investments
Pennsylvania
$242K -$347K -4,830 -60%
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$230K -$15.8K -219 -7%
Prudential Financial
56
Prudential Financial
New Jersey
$215K -$21.6K -300 -9%
MLICM
57
Metropolitan Life Insurance Company (MetLife)
New York
$210K -$14.6K -203 -7%
HW
58
Hancock Whitney
Mississippi
$210K +$205K +2,850 New
SO
59
STRS Ohio
Ohio
$198K
AIG
60
American International Group
New York
$168K +$12.3K +171 +8%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$97K +$12.2K +169 +15%
Legal & General Group
62
Legal & General Group
United Kingdom
$76K +$14K +195 +23%
OAM
63
Oppenheimer Asset Management
New York
$67K +$7.12K +99 +12%
Barclays
64
Barclays
United Kingdom
$50K +$34.4K +478 +238%
FDCDDQ
65
Federation des caisses Desjardins du Quebec
Quebec, Canada
$31.3K
FPS
66
Fieldpoint Private Securities
Connecticut
$27K +$26.8K +372 New
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
$26K -$5.39K -75 -17%
PNC Financial Services Group
68
PNC Financial Services Group
Pennsylvania
$23K +$432 +6 +2%
AIP
69
Ameritas Investment Partners
Nebraska
$21K
Bank of America
70
Bank of America
North Carolina
$18K +$17K +237 +5,925%
TRCT
71
Tower Research Capital (TRC)
New York
$15K +$9.13K +127 +174%
Nisa Investment Advisors
72
Nisa Investment Advisors
Missouri
$11K
AG
73
Advisor Group
Arizona
$6K
DA
74
Denali Advisors
California
$5K +$2.23K +31 +94%
TC
75
TFS Capital
Pennsylvania
-$234K -3,226 Closed

UTMD Hedge Fund Activity: Q3 2017 in Review

74 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2017, worth a combined $182M — up 1.7% from $179M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of UTMD and 2 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 35 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.92M. The largest seller was American Century Companies, cutting an estimated $6.72M.

  • 74 institutional investors held Utah Medical Products (UTMD) as of Q3 2017, down from 76 in Q2 2017.
  • Funds reported $182M of Utah Medical Products stock for Q3 2017, up 1.7% quarter-over-quarter.
  • 2 funds opened new Utah Medical Products positions in Q3 2017 and 4 closed out, a net change of -2 holders.
  • The largest Utah Medical Products buyer in Q3 2017 was Renaissance Technologies, an estimated $1.92M added.
  • The largest Utah Medical Products seller in Q3 2017 was American Century Companies, an estimated $6.72M sold.

Based on aggregated 13F filings for Q3 2017.